2023 CiteScore: 0.9
pISSN: 1735-8620
eISSN: 2008-2371
Editor-in-Chief:
Abbasali Karimi, MD.
Senior Associate Editor:
Ali Bozorgi, MD.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
Information for Authors
The first three consecutive issues of the Journal of Tehran University Heart Center were published under the title of the Journal of Tehran Heart Center with ISSN: 1735-5370. From the fourth issue onward, however, the journal has been entitled the Journal of Tehran University Heart Center with ISSN: 1735-8620.
Article Categories
The Journal of Tehran University Heart Center accepts the following categories of articles.
Original Article
Clinical and pre-clinical papers based on either normal subjects or patients and the result of cardiovascular pre-clinical research will be considered for publication provided they have an obvious clinical relevance.
The Journal of Tehran University Heart Center publishes a limited number of scholarly, comprehensive reviews which aims are to summarize and critically evaluate research in the field addressed and identify future implications. Reviews should not exceed 5000 words.
Letter to editor
Letters to the editor must not exceed 500 words and should focus on a specific article published in “the Journal of Tehran University Heart Center” within the preceding 12 weeks. No original data may be included. Authors will receive pre-publication proofs, and the authors of the article cited invited to reply.
Also Brief communication, Case reports & Review Articles will be accepted.
Submission of Manuscripts
Papers should typed in double spaced on A4 paper size. The cover letter should be prepared & subjected to journal Editor in Chief, Professor Abbas Karimi. Photocopies or good reproductions of illustrations are acceptable only on the spare copies. Included also should be a set of the electronic files of the manuscript on floppy- disk or CD-ROM. For preparation of electronic files , see the instructions herein below.
Also, manuscripts should be submitted electronically via the journal’s website: http://jthc.tums.ac.ir. Online submission allows the manuscript to be handled in electronic forms throughout the review process.
Review of manuscripts
All manuscript correctly submitted to will first be reviewed by the Editors. Some manuscripts will be returned to authors at this stage if the paper is deemed inappropriate for publication in “Journal of Tehran University Heart Center”, if the paper does not meet submission requirements, or if the paper is not deemed to have a sufficiently high priority. All papers considered suitable by the Editors to progress further in the review process will undergo appropriate peer review and all papers provisionally accepted for publication will undergo a detailed statistical review.
Preparation of manuscripts
All submitted manuscript must not exceed 5000 word, including References, Figure Legends and Tables. The number of tables, Figures and References should be appropriate to the manuscript content and should not be excessive. Authors should comply with the manuscript formatting and the ethical conventions of the ”Uniform Requirements for Manuscripts Submitted to Biomedical Journals” issued by the international committee of Medical Journal Editors (http://www.icmje.org)
Style and spelling
Authors whose first language is not English are requested to have their manuscripts checked carefully before submission. This will help expedite the review process and avoid confusion. Abbreviations of standard SI units of measurement only should be used.
Declaration of Helsinki
The authors should state that their study complies with the Declaration of Helsinki that the locally appointed ethics committee has approved the research protocol and that informed consent has been obtained from the subjects (or their guardians).
Clinical Trials
Authors should comply with the clinical trial registration statement from the ICMJE. More information can be found at www.icmje.org. Clinical trial reports should also comply with the consolidated Standards of Reporting Trials (CONSORT) and include a flow diagram presenting the enrollment, intervention allocation, follow–up, and data analysis with number of subjects for each (www.consort–statement.org). Please also refer specifically to the CONSORT Checklist of items to include when reporting a randomized clinical trial.
Section of the manuscripts
Original articles should be divided into the following section: (1) Title page,(2) Abstract and Keywords, (3) Introduction, (4) Methods, (5) Results, (6) Discussion, (7) Conclusion, (8) Acknowledgements, (9) References. (10) Figure legends, (11) Tables & (12) Figures.
General format
Prepare your manuscript text using a word processing package. Submissions of text in the form of PDF files are not permitted. Manuscript should be double – spaced, including text, tables, legends and references. Number each page. Please avoid footnotes; use instead, and as sparingly as possible, parenthesis within brackets. Enter text in the style and order of the Journal. Type references in the correct order and style of the journal . Type unjustified, without hyphenation, except for compound words. Type headings in the style of the journal. Use the TAB key once for paragraph indents. Where possible use times New Roman for the Text font and Symbol for the Greek and Special Characters. Use the Word Processing formatting features to indicate Bold, Italic, Greek, Maths, Superscript and subscript characters. Clearly identify unusual symbols and Greek letters, Differentiate between the letter o and zero, and the letters I and I and the number 1 Mark the approximate position of each figure and table. Check the final copy of your paper carefully, as any spelling mistakes and errors may be translated into the typeset version.
Title page
The title page should include the following:
Title of the Article
Authors’ Names and Degrees
Example:
Masih Tajdini, MD1,2*, Amir Hossein Behnoush, MD-MPH1, Amirmohammad Khalaji, MD1 , Satish R Raj, MD3
Institution(s) Where Work Was Performed
Institution and Location of All Authors
Example:
1Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
2Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, USA.
3Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
ORCID of All Authors
Corresponding Author Information
Example:
*Corresponding Author: Mohammad Ali Boroumand, Professor of Pathology, Tehran University of Medical Sciences, Department of Pathology, School of Medicine, Tehran Heart Center, North Kargar Street, Tehran, Iran. 1411713138. Tel: +98 21 88029256. Fax: +98 21 8029257. E-mail: borumand@sina.tums.ac.ir
Abstract
All abstracts may not contain more than 250 words and should also be submitted as a separate file, the abstract should be formatted with the following heading: (1) Background, (2) Methods, (3) Results & (4) Conclusion.
Keywords
All Keywords should be available at MeSH (Medical Subject Headings).
A Maximum of six Keywords may be submitted.
Formatting Requirements for Figures
Numbering and Titles
Figure Legends
Image Quality
File Format
Accessibility
Submission Guidelines
Figure Details
For each figure, please include the following items:
a) Explain the content of the figure.
b) Describe the perspective or view depicted in the figure.
c) Name all important landmarks in the figure using abbreviations and define them in the legend.
d) Indicate the most important findings in the figure using arrow(s).
e) Clearly explain what the figure demonstrates.
f) Provide the original version of your figure without any edits.
Tables
Acknowledgements
All sources of approved and supported, and substantive contributions of individuals, should be noted in the Acknowledgements, positioned before the list of references.
(This study was approved and supported by ... )
Reference format
All references must be available on PubMed and formatted according to the National Library of Medicine (NLM) style.
Author(s). Title of article. Abbreviated Journal Title. Year; Volume: Page numbers. PubMed PMID: [number].
Example:
Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006 Apr 20;354(16):1698-705. PubMed PMID: 16625009.
Author(s) of the chapter. Title of chapter. In: Main author(s) of the book (eds.). Title of book. Edition. Place of publication: Publisher; Year. p. Page numbers.
Example:
Chapter citation example: 2.Nichols WW, O’Rourke MF. Aging, high blood pressure and disease in humans. In : Arnold E, ed. McDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London/Melbourne/Auckland: Lea and Febiger; 1990.p.398-420
Example:
Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. eJIFCC. http://www.ifcc.org/ejifcc/vo114no2/1402062003014n.htm (Accessed 28 May 2004).
Statistics
All manuscript selected for publication will be reviewed for the appropriateness and accuracy of the statistical methods used and the interpretation of statistical results. All papers submitted should provide in their Methods section a subsection detailing the statistical methods, including the specific method used to summarize the data, the methods used to test their hypothesis testing and (if any) the level of significance used for hypothesis testing.
Conflict of interest
At submission, the editors require authors to disclose any financial association that might pose a conflict of interest in connection with the submitted article. All sources of funding for the work should be acknowledged in a footnote on the title page and in the Acknowledgements within the manuscript, as should all the institutional affiliations of the authors (including corporate appointments). Other kinds of associations, such as consultancies, stock ownership or other equity interest or patent – licensing arrangements should be disclosed to the editors in the cover letter at the time of the of submission. If no conflict of interest exists, please state this in the cover letter.
Proofs
Page proofs will be sent to the corresponding author. Please provide an e-mail address to enable page proofs to be sent as PDF files via e-mail. These should be checked thoroughly for any possible changes or typographic errors. Significant alterations instigated at this stage by the author will be charged to the author. It is the intention of the Editor to review, correct and publish your article as quickly as possible. To achieve this it is important that all of your corrections are returned to us in one all-inclusive mail or fax. Subsequent additional corrections will not be possible, so please ensure that your first communication is complete.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Focus and Scope
The Journal of Tehran University Heart Center aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular Medicine. It includes articles related to research findings. Technical evaluations, and reviews. In addition, it provides a forum for the exchange of information on all aspects of Cardiovascular Medicine, including educational issues. “ the journal of Tehran University Heart Center” is an International, English language, peer reviewed journal concerned with Cardiovascular Medicine. It is an official Journal of the Cardiovascular Research Center of the Tehran University of Medical Sciences (in collaboration with the Iranian Society of Cardiac Surgeons) and is published quarterly. Papers submitted to this journal which do not adhere to the Instructions for Authors will be returned for appropriate revision to be in line with the instructions for authors. They may then be resubmitted. Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form. In English or in any other language, without the written consent of the publisher.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
2023 CiteScore: 0.9
pISSN: 1735-8620
eISSN: 2008-2371
Editor-in-Chief:
Abbasali Karimi, MD.
Senior Associate Editor:
Ali Bozorgi, MD.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source. |